Adult Vaccinations Today—Innovations and Challenges for the Coming Years

Routine pediatric vaccinations have resulted in dramatic declines in the incidence and complications of several vaccine-preventable diseases (VPDs) over the past fifty years. At the same time, the prolongation of life expectancy and the large number of adults living with chronic medical conditions changed the demographic profile and, accordingly, the healthcare needs. The recognition of the burden and effects of several VPDs in adults and in particular risk groups and the comprehension of the age-dependent deterioration of immune responses have driven the extension of routine vaccination programs beyond adolescence. In addition, several VPDs emerged or re-emerged over the past decades, and new vaccines have been developed or are under clinical assessment. Currently, vaccination programs in many countries include vaccinations for adults, aiming to expand and strengthen protection throughout the lifespan and promote healthy aging. Moreover, there are needs for new or more effective vaccines against common or emerging pathogens and public health threats, including chronic diseases. This article reviews the current status of several adult vaccinations and discusses challenges for adult vaccinations, including new vaccines, emerging or re-emerging VPDs, and strategies to overcome low vaccination rates

Vaccination Programs for Adults in Europe, 2019

Background: While all European countries implement vaccination programs for children, there are gaps in terms of vaccination programs for adults. Methods: We studied the 2019 vaccination policies for adults in 42 European countries. Results: Vaccination programs for adults were in place in all countries. However, there were considerable differences between countries in terms of number of vaccinations, target populations and frame of implementation (recommended or mandatory vaccinations). In particular the following vaccination policies were in place: influenza (42 countries), tetanus (31), diphtheria (30), pneumococcus (29), hepatitis B (20), pertussis (18), measles (14), human papilloma virus (14), meningococcus tetravalent A,C,W,Y (14), rubella (13), hepatitis A (11), mumps (11), poliomyelitis (10), herpes zoster (9), varicella (8), tick-born encephalitis (8), meningococcus B (6), rabies (6), Haemophilus influenzae type b (5), tuberculosis (3), typhoid fever (3), meningococcus C (2), and yellow fever (1). Seventeen countries implement mandatory vaccinations, mainly against diphtheria, tetanus and hepatitis B. Conclusions: There are significant differences in vaccination programs for adults in Europe. Routine vaccination programs for adults need to be strengthened. A consensus-based vaccination program is needed

Vaccination Programs for Adults in Europe, 2019

Background: While all European countries implement vaccination programs for children, there are gaps in terms of vaccination programs for adults. Methods: We studied the 2019 vaccination policies for adults in 42 European countries. Results: Vaccination programs for adults were in place in all countries. However, there were considerable differences between countries in terms of number of vaccinations, target populations and frame of implementation (recommended or mandatory vaccinations). In particular the following vaccination policies were in place: influenza (42 countries), tetanus (31), diphtheria (30), pneumococcus (29), hepatitis B (20), pertussis (18), measles (14), human papilloma virus (14), meningococcus tetravalent A,C,W,Y (14), rubella (13), hepatitis A (11), mumps (11), poliomyelitis (10), herpes zoster (9), varicella (8), tick-born encephalitis (8), meningococcus B (6), rabies (6), Haemophilus influenzae type b (5), tuberculosis (3), typhoid fever (3), meningococcus C (2), and yellow fever (1). Seventeen countries implement mandatory vaccinations, mainly against diphtheria, tetanus and hepatitis B. Conclusions: There are significant differences in vaccination programs for adults in Europe. Routine vaccination programs for adults need to be strengthened. A consensus-based vaccination program is needed.</jats:p

Constipation and Dilated Bowel: Hirschsprung’s Disease Is Not Always the Case

A case of a 2-month-old boy with constipation and a localized abdominal distension in the right abdomen and hypogastrium is presented. Plain radiograph, ultrasound exam as well as a barium enema were suggestive of Hirschsprung’s disease (HD) (ultrashort segment disease). Nevertheless, rectal suction biopsy was negative for neuronal abnormalities and unexpectedly on plain radiograph vertebral abnormalities were noticed. Subsequently magnetic resonance imaging of the spine and abdomen was performed, to evaluate possible spinal cord lesions and potential abnormalities of the perineal region musculature. A syringe throughout medullary cone was noted. The well-known issue, that the diagnosis of HD does not depend on the imaging (radiological) findings, was confirmed. The step-bystep diagnostic approach from the initial thought of ultrashort segment HD to the later imaging-based diagnosis of syringomyelia is discussed in this present paper.</jats:p

sj-pdf-1-chc-10.1177_13674935211055294 – Supplemental Material for Vaccination programs for children aged up to 18 years in Europe, 2020

Supplemental Material, sj-pdf-1-chc-10.1177_13674935211055294 for Vaccination programs for children aged up to 18 years in Europe, 2020 by Evgnosia Effraimidou, Dimitrios C Cassimos, Snezana Medic, Maria Topalidou, Maria Theodoridou and Helena C Maltezou in Journal of Child Health Care</p